Experiences across a genetic screening and testing programme pathway: a qualitative study of mammogram patient perspectives
Open Access
Abstract
Background Population-based genetic screening and testing programmes have substantial potential to improve cancer-related outcomes through early detection and cancer prevention. Yet, genetic testing for cancer risk remains largely underused. This study aimed to describe barriers and facilitators to patient engagement at each stage of a California-based genetic screening programme, from completing the electronic screener to receiving the test and to identify potential improvements that could support precision medicine-based approaches to patient care. Methods We conducted 26 semistructured interviews among programme participants who did not complete the screener (n=9), those who did not receive the recommended test (n=7) and those who received a genetic test (n=10). Interviewees were selected from patients who recently received a mammogram through one of the participating Southern California clinics. Interviews were transcribed and coded using Atlas.ti. The study used a qualitative descriptive approach to identify similar and contrasting themes among the participant groups. Results This study found that barriers and facilitators to engagement were largely the same regardless of how far participants had moved through the process towards getting a genetic test. We identified four overarching themes: participants wanted clear communication of personal benefits at each stage; participants needed additional information and knowledge to navigate genetic screening and testing; a trusted provider could be instrumental in participants following a recommendation; and repetition and timing strongly impacted participants’ likelihood to engage. Conclusions Providing education about the benefits of genetic screening and testing to patients and their families, as well as clear communication about what each step entails may help patients engage with similar programmes. Strategies aimed at increasing coordination among a patient’s healthcare team can also help ensure information reaches patients in multiple ways, from multiple providers, to increase the likelihood that recommendations for testing come from trusted sources, which supports the uptake of genetic testing.Keywords
Funding Information
- Providence St. Joseph Health (N/A)
- Providence Foundation (N/A)
This publication has 31 references indexed in Scilit:
- Psychosocial factors impacting barriers and motivators to cancer genetic testingCancer Medicine, 2023
- Genetic Testing in the Latinx community: Impact of acculturation and provider relationshipsGynecologic Oncology, 2022
- Motivations and barriers to pursue cancer genomic testing: A systematic reviewPatient Education and Counseling, 2021
- A systematic review of communication interventions to help healthcare professionals discuss genetic testing for breast cancerBreast Cancer Research and Treatment, 2020
- Population-based genetic testing for Women's cancer preventionBest Practice & Research Clinical Obstetrics & Gynaecology, 2020
- Knowledge, attitudes, and perceived barriers towards genetic testing across three rural Illinois communitiesJournal of Community Genetics, 2019
- Precision Medicine: Familiarity, Perceived Health Drivers, and Genetic Testing Considerations Across Health Literacy Levels in a Diverse SampleJournal of Genetic Counseling, 2018
- Development and Evaluation of a Telephone Communication Protocol for the Delivery of Personalized Melanoma Genomic Risk to the General PopulationJournal of Genetic Counseling, 2017
- Primary care providers’ cancer genetic testing-related knowledge, attitudes, and communication behaviors: A systematic review and research agendaJournal of General Internal Medicine, 2016
- Translational genomic research: protocol development and initial outcomes following SNP testing for colon cancer riskTranslational Behavioral Medicine, 2012